Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y ▼ |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 0.100% | 0.816% | 10.731% | 96.486% | 56.742% | 354.600% | 716.979% |
| Alnylam Pharmace. | 4.150% | 3.403% | 12.080% | -12.458% | -12.458% | 5.732% | 139.527% |
| Ocular Therapeutix Inc. | 2.780% | 8.454% | 8.939% | 30.990% | 39.418% | -51.653% | 57.406% |
| Savara Inc. | -1.160% | -10.471% | -10.938% | 30.534% | -20.833% | 140.845% | 50.727% |
| Evotec SE | -2.120% | -1.429% | -9.409% | -60.888% | -61.236% | -77.365% | -65.926% |
| G1 Therapeutics | -1.270% | -10.607% | -40.298% | -3.083% | -15.418% | -87.300% | - |
| Cellectar BioSciences Inc. | 2.270% | -13.548% | -5.634% | 54.023% | 17.544% | -73.465% | - |
| Mereo BioPharma Group PLC | - | - | - | - | - | - | - |
| QIAGEN NV | -0.150% | - | - | - | - | - | - |
| Viking Therapeutics Inc | 5.330% | 1.461% | -13.491% | 163.619% | 182.013% | 869.143% | - |